Strengths

● Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 50% by 2025.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Its low valuation, with P/E ratio at 8.87 and 7.63 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.

● The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.


Weaknesses

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.